Foreign Corrupt Practices Act: Investigations Dataset

Investigation Name: Investigation into Bristol-Myers Squibb Company's Activities in Germany

Trend: None

Type of investigation: SEC

Other Agencies Investigating/Assisting with SEC Investigation:

German Staatsanwaltin Prosecutor

Whistleblower: Unknown

Summary

Bristol-Myers Squibb Company ("Bristol"), a Delaware corporation based in New York, NY, developed, licensed, manufactured, marketed, distributed, and sold pharmaceutical and over-the-counter products on a worldwide basis. The common stock of Bristol is registered with the SEC and trades on the New York Stock Exchange.

According to filings by Bristol, on October 25, 2004, the SEC notified Bristol that an informal inquiry into the activities of certain of Bristol’s German pharmaceutical subsidiaries and its employees and/or agents, was underway. Bristol believed the SEC’s inquiry encompassed matters under investigation by the Staatsanwaltin prosecutor in Munich, Germany, and that both the SEC’s inquiry and German investigation concerned potential violations of the Foreign Corrupt Practices Act and/or German law.

In October 2006, the SEC informed Bristol that the inquiry had become formal.

The last disclosure of this investigation was made by Bristol in its July 23, 2015 10-Q filing.

Protected Content

Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.

| Investigations Dataset

Investigations Dataset

Information & Summary

Investigation into Bristol-Myers Squibb Company's Activities in Germany

Information & Summary

Protected Content